Research graph
References from Chest wall pain as a late effect following radiotherapy for breast cancer: A systematic review of prevalence and risk factors. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Unresolved reference
2025 · External reference
Early breast cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up
10.1016/j.annonc.2023.11.016 · 2024 · External reference
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials
2011 · External reference
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
2011 · External reference
Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark
10.1016/j.ejpain.2008.05.015 · 2009 · External reference
Late effects arising from volumetric modulated arc therapy to the breast: a systematic review
10.1016/j.radi.2020.08.003 · 2021 · External reference
Unresolved reference
2025 · External reference
Cancer Survivorship 1 Management of common clinical problems experienced by survivors of cancer
10.1016/s0140-6736(22)00242-2 · 2022 · External reference
Healthcare professionals' knowledge, understanding and confidence to manage chronic pain after cancer treatment: a UK survey
10.1016/j.ejon.2024.102610 · 2024 · External reference
Late effects of breast cancer treatment and potentials for rehabilitation
10.3109/0284186x.2010.533190 · 2011 · External reference
Persistent pain after breast cancer treatment, an underreported burden for breast Cancer survivors
10.1245/s10434-024-15682-2 · 2024 · External reference
Predictors of persistent pain after breast cancer surgery: a systematic review and meta-analysis of observational studies
10.1503/cmaj.151276 · 2016 · External reference
Living with chronic pain: perceptions of breast cancer survivors
10.1007/s10549-018-4670-9 · 2018 · External reference
Chronic pain and other symptoms among breast cancer survivors: prevalence, predictors, and effects on quality of life
10.1007/s10549-017-4485-0 · 2018 · External reference
Upper body pain and functional disorders in patients with breast cancer
10.1016/j.pmrj.2013.08.605 · 2014 · External reference
Prevalence of pain in patients with breast cancer post-treatment: a systematic review
10.1016/j.breast.2018.08.105 · 2018 · External reference
Pain associated with breast cancer: etiologies and therapies
2023 · External reference
Risk factors for persistent pain after breast and thoracic surgeries: a systematic literature review and meta-analysis
10.1097/j.pain.0000000000002301 · 2022 · External reference
Patient-reported pain in patients with breast cancer who receive radiotherapy
10.1016/j.pmn.2020.12.007 · 2021 · External reference
Unresolved reference
2022 · External reference
Radiotherapy toxicities: mechanisms, management, and future directions
10.1016/s0140-6736(24)02319-5 · 2025 · External reference
Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: a randomized clinical trial
10.1001/jamaoncol.2015.2666 · 2015 · External reference
Radiotherapy toxicity
10.1038/s41572-019-0064-5 · 2019 · External reference
Predictive factors for late normal tissue complications following radiotherapy for breast cancer
10.1007/s10549-006-9480-9 · 2007 · External reference
Dose constraints in breast cancer radiotherapy. A critical review
10.1016/j.radonc.2024.110591 · 2025 · External reference
Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis
10.1136/bmj-2023-079089 · 2024 · External reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
2021 · External reference
Unresolved reference
2023 · External reference
CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment
10.1016/s1053-4296(03)00031-6 · 2003 · External reference
Unresolved reference
2009 · External reference
Unresolved reference
2017 · External reference
EORTC late effects working group. Late effects toxicity scoring: the SOMA scale
10.1016/0167-8140(95)97448-m · 1995 · External reference
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology
10.1093/jnci/85.5.365 · 1993 · External reference
The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study
10.1200/jco.1996.14.10.2756 · 1996 · External reference
An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45
10.1016/j.annonc.2019.10.027 · 2019 · External reference
A multicenter investigation of late adverse events in Japanese women treated with breast-conserving surgery plus conventional fractionated whole-breast radiation therapy
10.1093/jjco/hys050 · 2012 · External reference
Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months’ follow-up
10.1016/j.ijrobp.2012.01.050 · 2012 · External reference
Postmastectomy hypofractionated and accelerated radiation therapy with (and without) subcutaneous amifostine cytoprotection
10.1016/j.ijrobp.2012.08.017 · 2013 · External reference
Simultaneous integrated boost by intensity modulated radiotherapy (SIB-IMRT) in patients undergoing breast conserving surgery-a clinical and dosimetric perspective
10.1016/j.jnci.2018.10.001 · 2018 · External reference
5-year update of a multi-institution, prospective phase 2 hypofractionated postmastectomy radiation therapy trial
10.1016/j.ijrobp.2020.03.020 · 2020 · External reference
Patient-reported symptoms of late toxicity in patients with breast Cancer treated with Hypofractionated radiation therapy and the association with quality of life
10.1016/j.ijrobp.2022.11.008 · 2023 · External reference
External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial
10.1016/s0140-6736(19)32515-2 · 2019 · External reference
Toxicity of external beam accelerated partial-breast irradiation (APBI) in adjuvant therapy of early-stage breast cancer: prospective randomized study
10.1186/s13014-024-02412-x · 2024 · External reference
Accelerated partial breast irradiation using 3D conformal radiotherapy: toxicity and cosmetic outcome
10.1016/j.breast.2013.07.042 · 2013 · External reference
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
10.1016/0360-3016(95)00060-c · 1995 · External reference
Postoperative radiotherapy in women with early operable breast cancer (Scottish Breast Conservation Trial): 30-year update of a randomised, controlled, phase 3 trial
10.1016/s1470-2045(24)00347-4 · 2024 · External reference
Patient-reported outcomes over 5 years after whole-or partial-breast radiotherapy: longitudinal analysis of the IMPORT LOW (CRUK/06/003) phase III randomized controlled trial
10.1200/jco.18.00982 · 2019 · External reference
Are patient-reported outcomes useful in post-treatment follow-up care for women with early breast cancer? A scoping review
10.2147/prom.s195296 · 2019 · External reference
Reporting of late morbidity after radiation therapy in large prospective studies: a descriptive review of the current status
10.1016/j.ijrobp.2019.08.040 · 2019 · External reference
The Cambridge breast intensity-modulated radiotherapy trial: comparison of clinician-versus patient-reported outcomes
10.1016/j.clon.2016.02.011 · 2016 · External reference
Can patient-reported outcomes be used instead of clinician reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial
10.1016/j.radonc.2019.01.036 · 2019 · External reference
Identifying patients whose symptoms are underrecognized during treatment with breast radiotherapy
10.1001/jamaoncol.2022.0114 · 2022 · External reference
Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trial
10.1038/s41591-025-03507-y · 2025 · External reference
Unresolved reference
2022 · External reference
Changes in pectoralis major stiffness and thickness following radiotherapy for breast cancer: a 12-month follow-up case series
2022 · External reference
Unresolved reference
2019 · External reference
Integrating electronic patient-reported outcome measures (ePROMs) into personalised follow-up for patients after radiotherapy. A feasibility study
2025 · External reference
Unresolved reference
2020 · External reference
On the sensitivity of PROMs during breast radiotherapy
2023 · External reference
Tangential beam IMRT versus tangential beam 3D-CRT of the chest wall in postmastectomy breast cancer patients: a dosimetric comparison
10.1186/1748-717x-6-26 · 2011 · External reference
Prone versus supine positioning for whole and partial-breast radiotherapy: a comparison of non-target tissue dosimetry
10.1016/j.radonc.2010.05.014 · 2010 · External reference
Prone positioning causes the heart to be displaced anteriorly within the thorax: implications for breast cancer treatment
10.1016/j.ijrobp.2007.11.001 · 2008 · External reference
The prone-position whole breast irradiation paradox: where do we stand? A comprehensive review
10.3390/jcm15010390 · 2026 · External reference
Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity
10.1259/bjr.20150628 · 2016 · External reference
Characterization of Chest Wall toxicity during long-term follow up after thoracic stereotactic body radiation therapy
10.1016/j.prro.2019.01.012 · 2019 · External reference
Master breast radiation planning: simple guide for radiation oncology residents
2024 · External reference
ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer
10.1016/j.radonc.2014.11.030 · 2015 · External reference
Radiation-induced fibrosis: mechanisms and implications for therapy
10.1007/s00432-015-1974-6 · 2015 · External reference
Unresolved reference
2024 · External reference
REQUITE: a prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer
10.1016/j.radonc.2019.04.034 · 2019 · External reference
